- Home
- RGCO vs LXEO Comparison
RGCO vs LXEO Comparison
Compare RGCO & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGCO
- LXEO
- Stock Information
- Founded
- RGCO 1912
- LXEO 2017
- Country
- RGCO United States
- LXEO United States
- Employees
- RGCO N/A
- LXEO N/A
- Industry
- RGCO Oil & Gas Production
- LXEO
- Sector
- RGCO Utilities
- LXEO
- Exchange
- RGCO Nasdaq
- LXEO Nasdaq
- Market Cap
- RGCO 221.2M
- LXEO 257.0M
- IPO Year
- RGCO N/A
- LXEO 2023
- Fundamental
- Price
- RGCO $23.09
- LXEO $4.90
- Analyst Decision
- RGCO
- LXEO Strong Buy
- Analyst Count
- RGCO 0
- LXEO 7
- Target Price
- RGCO N/A
- LXEO $15.29
- AVG Volume (30 Days)
- RGCO 21.3K
- LXEO 395.5K
- Earning Date
- RGCO 08-11-2025
- LXEO 08-14-2025
- Dividend Yield
- RGCO 3.78%
- LXEO N/A
- EPS Growth
- RGCO 5.90
- LXEO N/A
- EPS
- RGCO 1.32
- LXEO N/A
- Revenue
- RGCO $94,120,500.00
- LXEO N/A
- Revenue This Year
- RGCO $10.87
- LXEO N/A
- Revenue Next Year
- RGCO $3.26
- LXEO N/A
- P/E Ratio
- RGCO $17.43
- LXEO N/A
- Revenue Growth
- RGCO 12.04
- LXEO N/A
- 52 Week Low
- RGCO $19.06
- LXEO $1.45
- 52 Week High
- RGCO $24.20
- LXEO $12.72
- Technical
- Relative Strength Index (RSI)
- RGCO 61.53
- LXEO 60.29
- Support Level
- RGCO $20.78
- LXEO $4.33
- Resistance Level
- RGCO $23.01
- LXEO $5.05
- Average True Range (ATR)
- RGCO 0.75
- LXEO 0.33
- MACD
- RGCO 0.14
- LXEO 0.01
- Stochastic Oscillator
- RGCO 96.48
- LXEO 73.18
About RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.